Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxcarbazepine in Chronic Asthma
NCT00142025Phase 4Completed
- Sponsor
- Centre of Chinese Medicine
- Start
- Sep 2001
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, double-blind trial in asthma comparing Oxcarbazepine + Usual Care with Placebo + Usual Care (2 arms). Primary endpoints: Change from baseline of the Forced Expiratory Volume in 1 second (FEV1) at 3 months, Change from baseline of the Peak Expiratory Flow Rate (PEFR) at 3 months and 1 more. Started Sep 2001; status: completed.
02
Drugs
oxcarbazepine
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00142025.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00142025.